Literature DB >> 12850867

Is there any association between uterine malignant mixed Mullerian tumour, breast cancer and prolonged tamoxifen treatment?

M M M Moe1, S El-Sharkawi.   

Abstract

Uterine malignant mixed Mullerian tumour is a very aggressive tumour of unknown aetiology. Previous pelvic irradiation, excessive oestrogen exposure, obesity and nulliparity have been incriminated in its aetiology. There is a paucity of data on the association between uterine mixed Mullerian tumour breast cancer and prolonged tamoxifen treatment. We report four patients who took tamoxifen for more than 7 years for breast cancer prior to their diagnosis with uterine mixed Mullerian tumour and also reviewed similar cases reported in the medical literature. The purpose of this article is to draw the attention of other professionals on this subject.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12850867     DOI: 10.1080/01443610310000100150

Source DB:  PubMed          Journal:  J Obstet Gynaecol        ISSN: 0144-3615            Impact factor:   1.246


  5 in total

1.  Malignant mixed Mullerian tumors.

Authors:  J Ruiz Tovar; M E Reguero Callejas; J I Arano Bermejo; L F Capote Armas; F González-Palacios Martínez; L Cabañas Navarro
Journal:  Clin Transl Oncol       Date:  2006-02       Impact factor: 3.405

Review 2.  Non-puerperal uterine inversion caused by malignant mixed mullerian sarcoma.

Authors:  Reeti Mehra; Sujata Siwatch; Sunita Arora; Reetu Kundu
Journal:  BMJ Case Rep       Date:  2013-12-12

3.  Mutational landscape implicates epithelial-mesenchymal transition gene TGF-β2 mutations for uterine carcinosarcoma after adjuvant tamoxifen therapy for breast carcinoma.

Authors:  Ling Shen; Liangli Hong; Songxia Zhou; Guohong Zhang; Ruiqin Mai
Journal:  Int J Clin Exp Pathol       Date:  2019-03-01

4.  Malignant mixed Mullerian tumors of the uterus: histopathological evaluation of cell cycle and apoptotic regulatory proteins.

Authors:  Rani Kanthan; Jenna-Lynn B Senger; Dana Diudea
Journal:  World J Surg Oncol       Date:  2010-07-19       Impact factor: 2.754

5.  Outcome and Predictive Factors in Uterine Carcinosarcoma Using Postoperative Radiotherapy: A Rare Cancer Network Study.

Authors:  Daniel R Zwahlen; Ulrike Schick; Yasemin Bolukbasi; Juliette Thariat; Roxolyana Abdah-Bortnyak; Abraham Kuten; Sefik Igdem; Hale Caglar; Zeynep Ozsaran; Kristina Loessl; Kaouthar Khanfir Belkaaloul; Sylviane Villette; Hansjörg Vees
Journal:  Rare Tumors       Date:  2016-06-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.